Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 28,231 | 27,986 | 28,563 | 27,872 | 26,280 |
| Gross Profit | 28,231 | 27,986 | 28,563 | 27,872 | 26,280 |
| Operating Expenses | 73,492 | 67,885 | 76,999 | 76,572 | 72,582 |
| Operating Income | -45,261 | -39,899 | -48,436 | -48,700 | -46,302 |
| Other Income | 1,342 | 2,337 | 834 | 1,550 | 625 |
| Pre-tax Income | -43,919 | -37,562 | -47,602 | -47,150 | -45,677 |
| Income Tax | 58 | -66 | 86 | 24 | 262 |
| Net Income Continuous | -43,977 | -37,496 | -47,688 | -47,174 | -45,939 |
| Minority Interests | N/A | N/A | N/A | -5 | -6 |
| Net Income | $-43,977 | $-37,496 | $-47,688 | $-47,169 | $-45,933 |
| EPS Basic Total Ops | -0.30 | -0.25 | -0.33 | -0.33 | -0.32 |
| EPS Basic Continuous Ops | -0.30 | -0.26 | -0.33 | -0.33 | -0.32 |
| EPS Diluted Total Ops | -0.30 | -0.25 | -0.33 | -0.33 | -0.32 |
| EPS Diluted Continuous Ops | -0.30 | -0.26 | -0.33 | -0.33 | -0.32 |
| EBITDA(a) | $-40,159 | $-34,590 | $-43,183 | $-43,502 | $-41,580 |